Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Is Now a Good Time to Buy This Biotech Stock?

TheMotleyFool

0 0

Is Now a Good Time to Buy This Biotech Stock?

To say that biotech Bluebird Bio (NASDAQ: BLUE) has significantly lagged the market in the past year would be an understatement. Shares of the gene-editing focused company have dropped by 89% in the trailing 12-month period, primarily due to various regulatory headwinds.

However, Bluebird recently received some good news that may signal a comeback is in the cards for the biotech. With this backdrop in mind, let's find out whether now is a good time to get in on Bluebird.